SEMINAR: �Lipoprotein metabolism and cardiovascular disease: Modeling models"

Hugh completed a PhD at the Baker Heart Research Institute and CSIRO’s Division of Human Nutrition in the field of lipoprotein metabolism. He subsequently spent eleven years at the University of Washington, Seattle, in the Department of Bioengineering, initially as a research fellow and finally as an Associate Professor. In 1999, he relocated to Perth. Hugh was an NHF Career Development Fellow and is currently an NHMRC research fellow. His research focuses on human lipid and lipoprotein metabolism and the development of compartmental models of biological systems. His primary focus is on the effect of lifestyle and pharmacological interventions developed to reduce cardiovascular disease, primarily in patients with the metabolic syndrome and diabetes.